Page last updated: 2024-11-01

niflumic acid and Carcinoma, Mucoepidermoid

niflumic acid has been researched along with Carcinoma, Mucoepidermoid in 1 studies

Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.

Carcinoma, Mucoepidermoid: A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hegab, AE1
Sakamoto, T1
Nomura, A1
Ishii, Y1
Morishima, Y1
Iizuka, T1
Kiwamoto, T1
Matsuno, Y1
Homma, S1
Sekizawa, K1

Other Studies

1 other study available for niflumic acid and Carcinoma, Mucoepidermoid

ArticleYear
Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: the role of hCLCA1.
    Chest, 2007, Volume: 131, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Bronchi; Bronchial Neoplasms; C

2007